Next Generation Probiotic MB310: $48M Boost for Ulcerative Colitis
by Dr. Pranab Gyawali | 14 days ago
SHEIKH ZAYED ROAD Encouraging news for ulcerative colitis patients! MB310, a next-generation probiotic treatment, has secured $48 million to advance into a larger Phase 2 clinical trial.
